Does MEDROXYPROGESTERONE Cause Product packaging issue? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product packaging issue have been filed in association with MEDROXYPROGESTERONE (Provera). This represents 0.1% of all adverse event reports for MEDROXYPROGESTERONE.
6
Reports of Product packaging issue with MEDROXYPROGESTERONE
0.1%
of all MEDROXYPROGESTERONE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging issue From MEDROXYPROGESTERONE?
Of the 6 reports.
Is Product packaging issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEDROXYPROGESTERONE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does MEDROXYPROGESTERONE Cause?
Meningioma (1,364)
Drug dose omission by device (510)
Device leakage (500)
Incorrect dose administered by device (410)
Drug ineffective (403)
Off label use (390)
Syringe issue (354)
Needle issue (346)
Headache (288)
Device occlusion (284)
What Other Drugs Cause Product packaging issue?
ACETAMINOPHEN (448)
LOPERAMIDE (351)
DIMETHICONE\LOPERAMIDE (348)
USTEKINUMAB (221)
FENTANYL (200)
MINOXIDIL (173)
CETIRIZINE (166)
ESTRADIOL (163)
GOLIMUMAB (95)
CYCLOSPORINE (93)
Which MEDROXYPROGESTERONE Alternatives Have Lower Product packaging issue Risk?
MEDROXYPROGESTERONE vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE
MEDROXYPROGESTERONE vs MEFENAMIC ACID
MEDROXYPROGESTERONE vs MEFLOQUINE
MEDROXYPROGESTERONE vs MEGESTROL
MEDROXYPROGESTERONE vs MEGLUMINE